Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.490
+0.080 (5.67%)
At close: Aug 13, 2025, 4:00 PM
1.490
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:45 AM EDT
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $107.48 million as of August 14, 2025. Its market cap has decreased by -63.70% in one year.
Market Cap
107.48M
Enterprise Value
-154.63M
1-Year Change
-63.70%
Ranking
Category
Stock Price
$1.49
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $107.48M, a decrease of -81.70%. That is a compound annual growth rate of -27.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 107.48M | -50.22% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | 2.11B | 259.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 590.40B |
| Johnson & Johnson | 419.82B |
| AbbVie | 355.56B |
| UnitedHealth Group | 244.77B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 225.13B |
| Novo Nordisk | 223.00B |